Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1441 AL 1455

[Clinical variants of pain syndromes in patients with Parkinson's disease]

Makhnev SO, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):39-44.

[Influence of levodopa, stalevo on dyskinesia in Parkinson's disease: STRIDE-PD study]

Liashchenko EA, Skripkina NA, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):62-8.

[The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson's disease]

Datieva VK, Rosinskaia AV, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):77-81.

Pathophysiological roles of serotonergic system in regulating extrapyramidal motor functions

Ohno Y, Shimizu S, Tokudome K.

Biol Pharm Bull. 2013;36(9):1396-400. doi: 10.1248/bpb.b13-00310.

[Eosinophilic fasciitis associated with Parkinson's syndrome - a case report]

Budisin V, Vrabec-Matković D, Milavac-Puretić V.

Reumatizam. 2013;60(1):37-41.

Comparison of once-daily versus twice-daily combination of ropinirole prolonged release in Parkinson's disease

Yun JY, Kim HJ, Lee JY, Kim YE, Kim JS, Kim JM, Jeon BS.

BMC Neurol. 2013 Sep 2;13:113. doi: 10.1186/1471-2377-13-113.

The prevalence of chronic diseases and multimorbidity in primary care practice: a PPRNet report

Ornstein SM, Nietert PJ, Jenkins RG, Litvin CB.

J Am Board Fam Med. 2013 Sep-Oct;26(5):518-24. doi: 10.3122/jabfm.2013.05.130012.

Comparison of the bioavailability and adhesiveness of different rotigotine transdermal patch formulations

Elshoff JP, Timmermann L, Schmid M, Arth C, Komenda M, Brunnert M, Bauer L.

Curr Med Res Opin. 2013 Dec;29(12):1657-62. doi: 10.1185/03007995.2013.841666. Epub 2013 Sep 23.

JNP special issue on Parkinson's disease and cognition

Edelstyn N, Poliakoff E.

J Neuropsychol. 2013 Sep;7(2):149-52. doi: 10.1111/jnp.12027.

Executive dysfunction in Parkinson's disease: a review

Dirnberger G, Jahanshahi M.

J Neuropsychol. 2013 Sep;7(2):193-224. doi: 10.1111/jnp.12028.

L-arginine and nitric oxide in CNS function and neurodegenerative diseases

Virarkar M, Alappat L, Bradford PG, Awad AB.

Crit Rev Food Sci Nutr. 2013;53(11):1157-67. doi: 10.1080/10408398.2011.573885.

[Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes]

Ohannessian A, Kaboré FA, Agostini A, Lenne Aurier K, Witjas T, Azulay JP, Karsenty G.

Prog Urol. 2013 Sep;23(11):936-9. doi: 10.1016/j.purol.2013.07.004. Epub 2013 Aug 6.

New pharmacological options for treating advanced Parkinson's disease

Devos D, Moreau C, Dujardin K, Cabantchik I, Defebvre L, Bordet R.

Clin Ther. 2013 Oct;35(10):1640-52. doi: 10.1016/j.clinthera.2013.08.011. Epub 2013 Sep 5.

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study

van Blitterswijk M, DeJesus-Hernandez M, Niemantsverdriet E, Murray ME, Heckman MG, Diehl NN, Brown PH, Baker MC, Finch NA, Bauer PO, Serrano G, Beach TG, Josephs KA, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Boylan KB, Petrucelli L, Dickson DW, Rademakers R.

Lancet Neurol. 2013 Oct;12(10):978-88. doi: 10.1016/S1474-4422(13)70210-2. Epub 2013 Sep 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias